About SPARK THERAPEUTICS, INC.
Spark Therapeutics, now fully integrated into the Roche Group, focuses on developing innovative therapies, particularly in the field of ophthalmology, with products such as Luxturna® (voretigene neparvovec-rzyl). The company emphasizes patient support and medical research.
Development of gene therapy treatmentsClinical trial supportPatient support servicesMedical information and resources for healthcare providers
Is this your company?
Claim SPARK THERAPEUTICS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim SPARK THERAPEUTICS, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.